124 related articles for article (PubMed ID: 21803039)
1. Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide.
Debache K; Guionaud C; Kropf C; Boykin D; Stephens CE; Hemphill A
Exp Parasitol; 2011 Oct; 129(2):95-100. PubMed ID: 21803039
[TBL] [Abstract][Full Text] [Related]
2. Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Hemphill A
Parasitology; 2012 Jun; 139(7):934-44. PubMed ID: 22309643
[TBL] [Abstract][Full Text] [Related]
3. Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.
Leepin A; Stüdli A; Brun R; Stephens CE; Boykin DW; Hemphill A
Antimicrob Agents Chemother; 2008 Jun; 52(6):1999-2008. PubMed ID: 18362190
[TBL] [Abstract][Full Text] [Related]
4. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of arylimidamides against Besnoitia besnoiti infection in Vero cells.
Cortes HC; Muller N; Boykin D; Stephens CE; Hemphill A
Parasitology; 2011 Apr; 138(5):583-92. PubMed ID: 21349220
[TBL] [Abstract][Full Text] [Related]
6. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.
Müller J; Aguado-Martinez A; Manser V; Balmer V; Winzer P; Ritler D; Hostettler I; Arranz-Solís D; Ortega-Mora L; Hemphill A
Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):16-25. PubMed ID: 25941626
[TBL] [Abstract][Full Text] [Related]
7. The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures.
Kropf C; Debache K; Rampa C; Barna F; Schorer M; Stephens CE; Ismail MA; Boykin DW; Hemphill A
Parasitology; 2012 Feb; 139(2):208-20. PubMed ID: 22011664
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
[TBL] [Abstract][Full Text] [Related]
9. Neospora caninum: in vivo and in vitro treatment with artemisone.
Mazuz ML; Haynes R; Shkap V; Fish L; Wollkomirsky R; Leibovich B; Molad T; Savitsky I; Golenser J
Vet Parasitol; 2012 Jun; 187(1-2):99-104. PubMed ID: 22260899
[TBL] [Abstract][Full Text] [Related]
10. In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum.
Müller J; Aguado A; Laleu B; Balmer V; Ritler D; Hemphill A
Int J Parasitol; 2017 Oct; 47(12):801-809. PubMed ID: 28751177
[TBL] [Abstract][Full Text] [Related]
11. Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice.
Debache K; Hemphill A
Vaccine; 2012 Jun; 30(28):4209-15. PubMed ID: 22537986
[TBL] [Abstract][Full Text] [Related]
12. Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.
Esposito M; Moores S; Naguleswaran A; Müller J; Hemphill A
Int J Parasitol; 2007 Aug; 37(10):1143-52. PubMed ID: 17481636
[TBL] [Abstract][Full Text] [Related]
13. NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum.
Strohbusch M; Müller N; Hemphill A; Greif G; Gottstein B
Parasitology; 2008 Aug; 135(9):1065-73. PubMed ID: 18549517
[TBL] [Abstract][Full Text] [Related]
14. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
[TBL] [Abstract][Full Text] [Related]
15. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
Alaeddine F; Keller N; Leepin A; Hemphill A
J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
[TBL] [Abstract][Full Text] [Related]
16. Toltrazuril treatment to control diaplacental Neospora caninum transmission in experimentally infected pregnant mice.
Gottstein B; Razmi GR; Ammann P; Sager H; Müller N
Parasitology; 2005 Jan; 130(Pt 1):41-8. PubMed ID: 15700756
[TBL] [Abstract][Full Text] [Related]
17. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
18. Identification of a host cell target for the thiazolide class of broad-spectrum anti-parasitic drugs.
Müller J; Hemphill A
Exp Parasitol; 2011 Jun; 128(2):145-50. PubMed ID: 21335006
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice.
Gottstein B; Eperon S; Dai WJ; Cannas A; Hemphill A; Greif G
Parasitol Res; 2001 Jan; 87(1):43-8. PubMed ID: 11199848
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model.
Arranz-Solís D; Aguado-Martínez A; Müller J; Regidor-Cerrillo J; Ortega-Mora LM; Hemphill A
Vet Parasitol; 2015 Jul; 211(3-4):133-40. PubMed ID: 26104964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
